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Background
The main limitation to a better knowledge of Autoin-
flammatory diseases is related to the fragmentation of
the diagnosed cases in different centers.
Aim
To evaluate the number of patients enrolled in the
Eurofever Registry in the first 15 months of enrolment.
Methods
A web-based registry collecting baseline and clinical infor-
mation on Autoinflammatory diseases is available on the
PRINTO web-site (www.printo.it). The registry is open to
all Pediatric Rheumatology centers and adult centers with
a specific interest in Autoinflammatory diseases. The
following monogenic autoinflammatory diseases were con-
sidered: FMF, CAPS, TRAPS, MKD, Blau’s syndrome,
PAPA, DIRA, NLRP12-mediated periodic fever. Informa-
tion on CRMO, Behcet’s disease, PFAPA and undefined
periodic fevers were also collected.
Results
During the first `15 months 1360 (M:F=652:708) patient
data from 64 centers in 28 countries have been entered
in the registry. So far clinical and genetic information
on the following patients has been collected: 376 FMF
pts; 156 TRAPS pts, 128 CAPS pts, 87 MKD pts; 13
Blau’s syndrome pts; 7 PAPA pts, 3 pts with NLRP-12
mediated periodic fever and 2 DIRA pts. In total 17 new
mutations have been reported. Data on 257 PFAPA
patients, 135 CRMO, 55 Behcet’s disease and 141
patients with undefined periodic fever are also available.
Conclusions
A common registry for collection of patients with Auto-
inflammatory disease is available and the enrolment is
ongoing. Data will be available for analysis of the clinical
presentation, outcome and response to treatment of
Autoinflammatory diseases and for comparative studies
among different Autoinflammatory conditions.
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